Is it clinically effective to treat arm flexor spasticity, with Botulinum toxin - type A (BoNTA) and physiotherapy, as soon as signs of abnormal muscle activity are observed

2015 ◽

Vol 18 (4) ◽

pp. 202-211 ◽

Cited By ~ 4

Author(s):

C. Y. Tsai ◽

Y. Y. Lei ◽

L. Y. Yang ◽

W. C. Chiu

Keyword(s):

Botulinum Toxin ◽

Muscle Activity ◽

Masseter Muscle ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Adult Rats

Download Full-text

The variability in the clinical effect induced by botulinum toxin type A: The role of muscle activity in humans

Movement Disorders ◽

10.1002/mds.870120115 ◽

1997 ◽

Vol 12 (1) ◽

pp. 89-94 ◽

Cited By ~ 77

Author(s):

R. Eleopra ◽

V. Tugnoli ◽

D. de Grandis

Keyword(s):

Botulinum Toxin ◽

Muscle Activity ◽

Clinical Effect ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type

Download Full-text

Comparison Between Intramuscular and Perimuscular Injections of Botulinum Toxin Type A

Yearbook of Plastic and Aesthetic Surgery ◽

10.1016/s1535-1513(08)70562-9 ◽

2008 ◽

Vol 2008 ◽

pp. 97

Author(s):

P. McKinney

Keyword(s):

Botulinum Toxin ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type

Download Full-text

Top-Accessed Article: Notalgia Paresthetica Treated With Botulinum Toxin Type A

Archives of Dermatology ◽

10.1001/archdermatol.2010.285 ◽

2010 ◽

Vol 146 (11) ◽

Cited By ~ 1

Author(s):

Gil Yosipovitch

Keyword(s):

Botulinum Toxin ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Notalgia Paresthetica

Download Full-text

Hip development in children with cerebral palsy and adductor spasticity treated with botulinum toxin type A: A two-year follow-up

Neuropediatrics ◽

10.1055/s-0029-1215844 ◽

2008 ◽

Vol 39 (05) ◽

Author(s):

NH Jung ◽

F Heinen ◽

A Reissig ◽

B Westhoff ◽

S Berweck ◽

...

Keyword(s):

Cerebral Palsy ◽

Botulinum Toxin ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Children With Cerebral Palsy

Download Full-text

Low rate of neutralising antibody formation to botulinum toxin type A in the course of treatment of primary axillary hyperhidrosis

Aktuelle Neurologie ◽

10.1055/s-2005-919411 ◽

2005 ◽

Vol 32 (S 4) ◽

Cited By ~ 1

Author(s):

M Naumann ◽

H Hamm ◽

D Glaser ◽

S Daggett ◽

C Kumar ◽

...

Keyword(s):

Botulinum Toxin ◽

Antibody Formation ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Axillary Hyperhidrosis ◽

Low Rate

Download Full-text

Botulinum Toxin Type A Therapy in Chronic Headache Patients

The Korean Journal of Pain ◽

10.3344/kjp.2005.18.1.29 ◽

2005 ◽

Vol 18 (1) ◽

pp. 29

Author(s):

Dong Eon Moon ◽

Young Eun Moon ◽

Shi Hyeon Kim ◽

Eun Sung Kim

Keyword(s):

Botulinum Toxin ◽

Chronic Headache ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Headache Patients

Download Full-text

Intra detrusor injections of botulinum toxin type A in children with spina bifida: a multicentric study

10.26226/morressier.59b63e41d462b8029238978e ◽

2017 ◽

Author(s):

Juliette Hascoet

Keyword(s):

Botulinum Toxin ◽

Spina Bifida ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Multicentric Study

Download Full-text

Faculty Opinions recommendation of Botulinum toxin type A treatment of multiple upper facial sites: patient-reported outcomes.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1066975.519943 ◽

2007 ◽

Author(s):

Jeanette Pitts

Keyword(s):

Botulinum Toxin ◽

Patient Reported Outcomes ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Patient Reported

Download Full-text

Faculty Opinions recommendation of Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1099029.555222 ◽

2008 ◽

Author(s):

Rodolfo Testa

Keyword(s):

Botulinum Toxin ◽

Chronic Inflammation ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Acute Injury ◽

Neuropeptide Release ◽

Rat Bladder

Download Full-text

Is it clinically effective to treat arm flexor spasticity, with Botulinum toxin - type A (BoNTA) and physiotherapy, as soon as signs of abnormal muscle activity are observed

Changes of masseter muscle activity following injection of botulinum toxin type A in adult rats

The variability in the clinical effect induced by botulinum toxin type A: The role of muscle activity in humans

Comparison Between Intramuscular and Perimuscular Injections of Botulinum Toxin Type A

Top-Accessed Article: Notalgia Paresthetica Treated With Botulinum Toxin Type A

Hip development in children with cerebral palsy and adductor spasticity treated with botulinum toxin type A: A two-year follow-up

Low rate of neutralising antibody formation to botulinum toxin type A in the course of treatment of primary axillary hyperhidrosis

Botulinum Toxin Type A Therapy in Chronic Headache Patients

Intra detrusor injections of botulinum toxin type A in children with spina bifida: a multicentric study

Faculty Opinions recommendation of Botulinum toxin type A treatment of multiple upper facial sites: patient-reported outcomes.

Faculty Opinions recommendation of Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation.

Export Citation Format